Crenessity (crinecerfont) Capsules and Oral Solution

CRENESSITY is a prescription medicine used to treat Adrenogenital Syndrome. FDA approved crinecerfont (brand name CRENESSITY) is not (yet) registered or available in India but on request Indian patient can buy CRENESSITY at the lowest price.

Crenessity-crinecerfont-Price-Delhi-India
Crenessity (crinecerfont) Capsules and Oral Solution

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Crenessity (crinecerfont) Capsules and Oral Solution

Crinecerfont is indicated as adjunctive treatment to glucocorticoid replacement to control androgens in people four years of age and older with classic congenital adrenal hyperplasia.

CRENESSITY is a corticortopin-releasing factor type 1 receptor antagonist to be used together with glucocorticoids (steroids) to control androgen levels in adults and pediatric patients aged 4 years and older with classic congenital adrenal hyperplasia.

Crinecerfont is indicated as adjunctive treatment to glucocorticoid replacement to control androgens in people four years of age and older with classic congenital adrenal hyperplasia.

NDA 218820
Drug Name: Crenessity
Active Ingredient: crinecerfont
Approval Date: 12/13/2024
FDA-approved use on approval date: To treat classic congenital adrenal hyperplasia
Company: Neurocrine Biosciences Inc.

Dosage Forms And Strengths:
Capsules: 25 mg, 50 mg, 100 mg
Oral Solution: 50 mg/mL

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.